Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
109 participants
INTERVENTIONAL
2018-08-27
2020-03-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dried fruit
100 g per day of dried fruit
food - dried fruit
raisins, apricots, figs, and pineapple
no dried fruit
no intervention to be given
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
food - dried fruit
raisins, apricots, figs, and pineapple
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* adequate dentition to chew dried fruit
* willing to avoid potassium supplements during the study
* willing to avoid antacids other than Pepto Bismol during the study
Exclusion Criteria
* diabetes or fasting plasma glucose on screening \>125 mg/dl
* untreated thyroid disease
* untreated parathyroid disease
* cirrhosis
* unstable heart disease
* osteoporosis of the spine or hip
* alcohol use \> 2 drinks per day
* chronic diarrheal syndrome
* estimated glomerular filtration rate \< 50 ml/min
* serum potassium \>5.3 meq/L
* abnormal serum calcium
* dysphasia
* malabsorption
* inflammatory bowel disease
* celiac disease
* chronic constipation
* gastric bypass surgery
* non-English speaking Medications
* potassium sparing diuretics
* oral glucocorticoids
* immunosuppressant drugs
* anabolic steroids in last 6 months
* estrogen in last 6 months
* osteoporosis treatment in the last 12 months with teriparatide abaloparatide calcitonin raloxifene denosumab
* osteoporosis treatment with a bisphosphonate in the last 2 years
* regular use of antacids \> 3 times per week
* regular use of laxatives \> 3 times per week
* any medication taken to alter appetite
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tufts Medical Center
OTHER
Tufts University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bess Dawson-Hughes
Director of Bone Metabolism Laboratory
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2980
Identifier Type: -
Identifier Source: org_study_id